Survival of Intravenous Edaravone-Treated Patients With ALS: Evidence From Administrative Claims Analyses. [PDF]
Brooks BR, Berry JD, Ciepielewska M.
europepmc +1 more source
Study on the improvement of electroencephalogram signal characteristics in stroke patients by edaravone dexborneol. [PDF]
Zhang S, Jiao H.
europepmc +1 more source
Edaravone Dexborneol in Large Ischemic Stroke: Real-World Experience from a Multicenter Study in China. [PDF]
Ma G +11 more
europepmc +1 more source
Crude Astragalus polysaccharides ameliorate cognitive impairment by preserving blood-brain barrier integrity and suppressing GSDMD-mediated pyroptosis in jellyfish-envenomed mice. [PDF]
Yao Z +5 more
europepmc +1 more source
Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial. [PDF]
Wang C +35 more
europepmc +1 more source
Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis. [PDF]
Genge A +17 more
europepmc +1 more source
Inflamed vessel-anchored release of H<sub>2</sub> across the blood-brain barrier for ischemic stroke neuroprotection. [PDF]
Yu Y +9 more
europepmc +1 more source
Effect of edaravone dexborneol on clinical outcomes in patients with acute posterior circulation ischemic stroke undergoing endovascular therapy: A retrospective single-center study. [PDF]
Luo J +5 more
europepmc +1 more source
Value of Clinical Evidence and Health Economics and Outcomes Research (HEOR) Studies. [PDF]
Abrahao A, Ciepielewska M, Zinman L.
europepmc +1 more source
Editorial: Advances and challenges in stroke therapy: a regenerative prospective, volume II. [PDF]
Raza SS, Morris VB, Azari H.
europepmc +1 more source

